Projects per year
Personal profile
Education
- 2004-2016 Ph.D., Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University
- 1999-2001 M.S., School of Medicine, Taipei Medical University
- 1987-1994 M.D., School of Medicine, Taipei Medical College
Experience
- Attending, Department of Pathology, Taipei Municipal Wanfang Hospital
- Director, Department of Pathology, Taipei Municipal Wanfang Hospital
- 2022.08- Director, Department of Pathology, School of Medicine, College of Medicin,e Taipei Medical University
- 2019.08- Associate Professor, Department of Pathology, School of Medicine, College of Medicin,e Taipei Medical University
- 2014.08-2019.07 Assistant Professor, Department of Pathology, School of Medicine, Taipei Medical University
- 2001.08-2014.07 Instructor, Department of Pathology, School of Medicine, Taipei Medical University
- 1996.09-2002.06 Resident Physician, Taipei Medical College Hospital
- 1996.07-1996.08 Resident Physician, Chang Gung Memorial Hospital
Research Interests
- Brain cancer, prostate cancer, cancer of gastrointestinal tract, immunohistochemistry, molecular pathology
Fingerprint
Dive into the research topics where Wei-Yu Chen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Exploring the Mechanism and Clinical Significance of Egfr/Suclg2/Vegfa Driving the Neuroendocrine Differentiation of Prostate Cancer
Chen, W.-Y. (PI)
8/1/23 → 7/31/26
Project: A - Government Institution › b - National Science and Technology Council
-
候選基因在子宮內膜異位、非癌性毛勒氏管組織，子宮內膜癌前病變和子宮內膜癌的表達(I/II)
Chen, W.-Y. (PI)
1/1/21 → 12/31/21
Project: B - Project of TMU › h - Higher Education Sprout Project
-
候選基因在子宮內膜異位、非癌性毛勒氏管組織，子宮內膜癌前病變和子宮內膜癌的表達(I/II)
Chen, W.-Y. (PI)
1/1/20 → 12/1/20
Project: B - Project of TMU › h - Higher Education Sprout Project
-
Targeting a Novel Neurotrophic Signaling Ngf-Chrm4 in Drug-Resistant Neuroendocrine Prostate Cancer
Chen, W.-Y. (PI)
8/1/19 → 7/31/20
Project: A - Government Institution › b - National Science and Technology Council
-
北醫大的表基因轉譯工作組-檢測人類組織中表基因和表轉錄基因機制
Chen, W.-Y. (PI)
1/1/19 → 12/1/19
Project: A - Government Institution › d - Ministry of Education
-
Binding of interleukin-1 receptor antagonist to cholinergic receptor muscarinic 4 promotes immunosuppression and neuroendocrine differentiation in prostate cancer
Liu, Y. N., Liu, M. K., Wen, Y. C., Li, C. H., Yeh, H. L., Dung, P. V. T., Jiang, K. C., Chen, W. H., Li, H. R., Huang, J. & Chen, W. Y., Aug 28 2024, In: Cancer Letters. 598, 217090.Research output: Contribution to journal › Article › peer-review
Open Access -
Correction: CHRM4/AKT/MYCN upregulates interferon alpha-17 in the tumor microenvironment to promote neuroendocrine differentiation of prostate cancer (Cell Death & Disease, (2023), 14, 5, (304), 10.1038/s41419-023-05836-7)
Wen, Y. C., Tram, V. T. N., Chen, W. H., Li, C. H., Yeh, H. L., Thuy Dung, P. V., Jiang, K. C., Li, H. R., Huang, J., Hsiao, M., Chen, W. Y. & Liu, Y. N., Jan 2024, In: Cell Death and Disease. 15, 1, 92.Research output: Contribution to journal › Comment/debate › peer-review
Open Access1 Citation (Scopus) -
Immunosuppressive role of BDNF in therapy-induced neuroendocrine prostate cancer
Liu, Y. N., Chen, W. Y., Liu, M. K., Yeh, H. L., Chen, W. H., Jiang, K. C., Li, H. R., Chen, Z. Q., Wang, W. H., Abou-Kheir, W. & Wen, Y. C., 2024, (Accepted/In press) In: Molecular Oncology. 18, 6, p. 1665-1686 22 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (Scopus) -
MCTP1 increases the malignancy of androgen-deprived prostate cancer cells by inducing neuroendocrine differentiation and EMT
Liu, Y. N., Chen, W. Y., Yeh, H. L., Chen, W. H., Jiang, K. C., Li, H. R., Thuy Dung, P. V., Chen, Z. Q., Lee, W. J., Hsiao, M., Huang, J. & Wen, Y. C., 2024, In: Science Signaling. 17, 840, adc9142.Research output: Contribution to journal › Article › peer-review
-
Mucinous cystadenocarcinoma of the breast harbours TRPS1 expressions and PIK3CA alterations
Chen, W. Y., Hu, Y. H., Tsai, Y. H., Hang, J. F., Tan, P. H. & Chen, C. J., Feb 2024, In: Histopathology. 84, 3, p. 550-555 6 p.Research output: Contribution to journal › Article › peer-review
Datasets
-
Additional file 1: of Disruption of ETV6 leads to TWIST1-dependent progression and resistance to epidermal growth factor receptor tyrosine kinase inhibitors in prostate cancer
Tsai, Y.-C. (Contributor), Zeng, T. (Creator), Abou-Kheir, W. (Creator), Yeh, H.-L. (Contributor), Yin, J. J. (Creator), Lee, Y.-C. (Creator), Chen, W.-Y. (Creator) & Liu, Y.-N. (Contributor), Figshare, 2018
DOI: 10.6084/m9.figshare.5900626.v1, https://springernature.figshare.com/articles/Additional_file_1_of_Disruption_of_ETV6_leads_to_TWIST1-dependent_progression_and_resistance_to_epidermal_growth_factor_receptor_tyrosine_kinase_inhibitors_in_prostate_cancer/5900626/1
Dataset
-
Disruption of ETV6 leads to TWIST1-dependent progression and resistance to epidermal growth factor receptor tyrosine kinase inhibitors in prostate cancer
Tsai, Y.-C. (Contributor), Zeng, T. (Creator), Abou-Kheir, W. (Creator), Yeh, H.-L. (Contributor), Yin, J. J. (Creator), Lee, Y.-C. (Creator), Chen, W.-Y. (Creator) & Liu, Y.-N. (Contributor), Figshare, 2018
DOI: 10.6084/m9.figshare.c.4008787.v1, https://doi.org/10.6084%2Fm9.figshare.c.4008787.v1
Dataset